{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:12:06Z","timestamp":1791670326367,"version":"4.3.4"},"reference-count":26,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J NeuroIntervent Surg"],"accepted":{"date-parts":[[2026,3,17]]},"abstract":"<jats:p>Prasugrel is a third-generation P2Y12 inhibitor that achieves faster, more consistent platelet inhibition than clopidogrel. Its use in the United States is limited by an U.S. Food and Drug Administration (FDA) boxed warning originating from TRITON-TIMI 38, which identified excess bleeding in patients aged 75 years or older, weighing less than 60\u2009kg, or with prior stroke or transient ischemic attack. That warning was developed in cardiology cohorts treated with fixed doses, while contemporary practice has diversified. European trials show prasugrel can be at least as effective as alternative P2Y12 inhibitors when patients are selected appropriately. Japanese and Korean experience with low-dose regimens (20\u2009mg loading\/3.75\u20135\u2009mg maintenance) suggests ischemic protection can be preserved with acceptable bleeding risk in smaller, higher-bleeding-risk populations. Neurointerventional series and meta-analyses in stent-assisted coiling and flow diversion report lower thromboembolic events and more predictable platelet inhibition, but the evidentiary signal is strongest in carefully selected patients with confirmed clopidogrel hyporesponsiveness or high on-treatment platelet reactivity treated with low-dose, platelet function-guided strategies. In these settings, hemorrhagic complication rates are generally similar to clopidogrel at low doses, although rare catastrophic intracranial hemorrhage has been described. This narrative review synthesizes cardiology and neurointerventional evidence to help clinicians interpret the boxed warning in context. The central message is to favor platelet function-guided and dose-adjusted therapy that targets a physiologic window of platelet reactivity, rather than relying on fixed cardiology dosing, and to prioritize prospective, neuro-specific studies that define optimal low-dose prasugrel strategies.<\/jats:p>","DOI":"10.1136\/jnis-2026-025144","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:20:35Z","timestamp":1776360035000},"page":"jnis-2026-025144","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Reassessing prasugrel\u2019s boxed warning: a review of dose adjustment, platelet function testing, and platelet reactivity unit (PRU)-guided strategies in neurointervention"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5899-5930","authenticated-orcid":false,"given":"Muhaison Hanifa","family":"Ibrahim","sequence":"first","affiliation":[{"name":"School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lee","sequence":"additional","affiliation":[{"name":"School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA"},{"name":"Neurosurgery, UW Health University Hospital, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"McGrath","sequence":"additional","affiliation":[{"name":"Neurosurgery, UW Health University Hospital, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Hess","sequence":"additional","affiliation":[{"name":"Neurosurgery, UW Health University Hospital, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Niemann","sequence":"additional","affiliation":[{"name":"School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA"},{"name":"Neurosurgery, UW Health University Hospital, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Aagaard-Kienitz","sequence":"additional","affiliation":[{"name":"School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA"},{"name":"Radiology, UW Health University Hospital, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Ahmed","sequence":"additional","affiliation":[{"name":"School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA"},{"name":"Neurosurgery, UW Health University Hospital, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Stone McGuire","sequence":"additional","affiliation":[{"name":"School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA"},{"name":"Neurosurgery, UW Health University Hospital, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2026041610202991000_jnis-2026-025144v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"key":"2026041610202991000_jnis-2026-025144v1.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.740324"},{"key":"2026041610202991000_jnis-2026-025144v1.3","unstructured":"U.S. Food and Drug Administration . Effient (prasugrel) tablets: prescribing information. 2020. Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/022307s018lbl.pdf [Accessed 12 Jan 2026]."},{"key":"2026041610202991000_jnis-2026-025144v1.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908973"},{"key":"2026041610202991000_jnis-2026-025144v1.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024823"},{"key":"2026041610202991000_jnis-2026-025144v1.6","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-13-1482"},{"key":"2026041610202991000_jnis-2026-025144v1.7","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3621"},{"key":"2026041610202991000_jnis-2026-025144v1.8","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4864"},{"key":"2026041610202991000_jnis-2026-025144v1.9","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-14-0266"},{"key":"2026041610202991000_jnis-2026-025144v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.104"},{"key":"2026041610202991000_jnis-2026-025144v1.11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1676545"},{"key":"2026041610202991000_jnis-2026-025144v1.12","doi-asserted-by":"publisher","DOI":"10.5469\/neuroint.2018.01088"},{"key":"2026041610202991000_jnis-2026-025144v1.13","first-page":"239","article-title":"Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence","volume":"13","author":"Gower","year":"2020","journal-title":"Pharmgenomics Pers Med"},{"key":"2026041610202991000_jnis-2026-025144v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.105"},{"key":"2026041610202991000_jnis-2026-025144v1.15","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.994184","article-title":"CYP2C19 loss-of-function alleles predicts clinical outcomes in East Asian patients with acute myocardial infarction undergoing percutaneous coronary intervention and stenting receiving clopidogrel","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026041610202991000_jnis-2026-025144v1.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809171"},{"key":"2026041610202991000_jnis-2026-025144v1.17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1572886","article-title":"CYP2C19 variability and clinical outcomes of clopidogrel, proton pump inhibitors, and voriconazole in Southeast Asia: a systematic review and meta-analysis","volume":"16","author":"Hardi","year":"2025","journal-title":"Front Pharmacol"},{"key":"2026041610202991000_jnis-2026-025144v1.18","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-014-0485-4","article-title":"\u201cEast asian paradox\u201d: challenge for the current antiplatelet strategy of \u201cone-guideline-fits-all races\u201d in acute coronary syndrome","volume":"16","author":"Jeong","year":"2014","journal-title":"Curr Cardiol Rep"},{"key":"2026041610202991000_jnis-2026-025144v1.19","doi-asserted-by":"crossref","unstructured":"Mitchell DL , McGuire LS , Khalid SI , et al . Assessing the efficacy of VerifyNow platelet-function testing in predicting postoperative hemorrhagic complications of neuroendovascular surgery: A systematic review and meta-analysis (part 2). Interv Neuroradiol 2024:15910199231225716. doi:10.1177\/15910199231225716","DOI":"10.1177\/15910199231225716"},{"key":"2026041610202991000_jnis-2026-025144v1.20","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2022-019844"},{"key":"2026041610202991000_jnis-2026-025144v1.21","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyx591"},{"key":"2026041610202991000_jnis-2026-025144v1.22","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2012-010334"},{"key":"2026041610202991000_jnis-2026-025144v1.23","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2023-020548"},{"key":"2026041610202991000_jnis-2026-025144v1.24","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6004"},{"key":"2026041610202991000_jnis-2026-025144v1.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205512"},{"key":"2026041610202991000_jnis-2026-025144v1.26","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2014-011111"}],"container-title":["Journal of NeuroInterventional Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnis-2026-025144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:20:39Z","timestamp":1776360039000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnis.bmj.com\/lookup\/doi\/10.1136\/jnis-2026-025144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":26,"alternative-id":["10.1136\/jnis-2026-025144"],"URL":"https:\/\/doi.org\/10.1136\/jnis-2026-025144","relation":{},"ISSN":["1759-8478","1759-8486"],"issn-type":[{"value":"1759-8478","type":"print"},{"value":"1759-8486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]}}}